Clinical and Biological Factors Associated with Pseudoprogression Under Immune Checkpoint Inhibitors: A Retrospective Pan-Tumor Cohort Study

Amélie Toulet, Valérie Seegers, Frédéric Bigot, Sylvère Guillemois, Damien Vansteene, Rémy Delva, Manon de Vries-Brilland

Open source

DOI
10.3390/cancers18183040
Published
2026-09-19
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18183040,
  title = {Clinical and Biological Factors Associated with Pseudoprogression Under Immune Checkpoint Inhibitors: A Retrospective Pan-Tumor Cohort Study},
  author = {Amélie Toulet and Valérie Seegers and Frédéric Bigot and Sylvère Guillemois and Damien Vansteene and Rémy Delva and Manon de Vries-Brilland},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18183040},
  url = {https://doi.org/10.3390/cancers18183040}
}

RIS

TY  - JOUR
TI  - Clinical and Biological Factors Associated with Pseudoprogression Under Immune Checkpoint Inhibitors: A Retrospective Pan-Tumor Cohort Study
AU  - Amélie Toulet
AU  - Valérie Seegers
AU  - Frédéric Bigot
AU  - Sylvère Guillemois
AU  - Damien Vansteene
AU  - Rémy Delva
AU  - Manon de Vries-Brilland
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18183040
UR  - https://doi.org/10.3390/cancers18183040
ER  - 

APA

Toulet, A., Seegers, V., Bigot, F., Guillemois, S., Vansteene, D., Delva, R., & Vries-Brilland, M. D. (2026). Clinical and Biological Factors Associated with Pseudoprogression Under Immune Checkpoint Inhibitors: A Retrospective Pan-Tumor Cohort Study. Cancers. https://doi.org/10.3390/cancers18183040

Source records